In addition to this, in the study by Ashikaga E et al., the fact that FGF-23 levels was not a marker of atherosclerosis despite the high level of phosphorus may be due to better nutritional status in hemodialysis patients with high phosphorus level. This evidence concerns the gene FGF23 and atherosclerosis.